Edesa Biotech
EDSA
NASDAQ
IPO2010
about EDSA
Edesa Biotech specializes in developing innovative treatments for rare genetic disorders through its focus on enzyme replacement therapy.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $2.50 | $4.35 | $2.42 | $19.03M | 29.76M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.28 | n/a | n/a | 0% | 0% | 0% |